Ignite Creation Date:
2024-05-05 @ 4:52 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00336700
Status:
TERMINATED
Last Update Posted:
2016-09-19
First Post:
2006-06-12
Brief Title:
A Phase II Study of Gemcitabine and Erlotinib As Adjuvant Therapy In Patients With Resected Pancreatic Cancer
Sponsor:
Herbert J Zeh III MD FACS
Organization:
University of Pittsburgh
Organization Data
Organization:
University of Pittsburgh
Class:
OTHER
Study ID:
06-016
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Herbert J Zeh III MD FACS
Lead Sponsor Class:
OTHER
Responsible Party:
Herbert J Zeh III MD FACS
Responsible Party Title:
Principal Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
University of Pittsburgh
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Genentech Inc | INDUSTRY |